IPG Photonics Corporation $IPGP Shares Acquired by QSM Asset Management Ltd

QSM Asset Management Ltd grew its stake in shares of IPG Photonics Corporation (NASDAQ:IPGP) by 95.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 51,832 shares of the semiconductor company’s stock after purchasing an additional 25,332 shares during the period. IPG Photonics comprises about 2.9% of QSM Asset Management Ltd’s holdings, making the stock its 17th biggest holding. QSM Asset Management Ltd owned 0.12% of IPG Photonics worth $4,058,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of IPGP. True Wealth Design LLC increased its stake in IPG Photonics by 1,621.7% in the 2nd quarter. True Wealth Design LLC now owns 396 shares of the semiconductor company’s stock worth $27,000 after purchasing an additional 373 shares in the last quarter. Nomura Asset Management Co. Ltd. boosted its holdings in shares of IPG Photonics by 207.1% in the second quarter. Nomura Asset Management Co. Ltd. now owns 430 shares of the semiconductor company’s stock worth $30,000 after buying an additional 290 shares during the period. EverSource Wealth Advisors LLC increased its position in shares of IPG Photonics by 348.2% in the second quarter. EverSource Wealth Advisors LLC now owns 744 shares of the semiconductor company’s stock worth $51,000 after acquiring an additional 578 shares in the last quarter. Signaturefd LLC raised its holdings in shares of IPG Photonics by 76.9% during the second quarter. Signaturefd LLC now owns 764 shares of the semiconductor company’s stock valued at $52,000 after acquiring an additional 332 shares during the period. Finally, Headlands Technologies LLC acquired a new stake in shares of IPG Photonics during the second quarter valued at approximately $65,000. Institutional investors and hedge funds own 93.79% of the company’s stock.

Insider Buying and Selling at IPG Photonics

In other IPG Photonics news, Director Tang Agnes sold 1,881 shares of IPG Photonics stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $76.75, for a total value of $144,366.75. Following the completion of the sale, the director directly owned 8,663 shares in the company, valued at $664,885.25. The trade was a 17.84% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Trevor Ness sold 1,681 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $75.58, for a total transaction of $127,049.98. Following the completion of the sale, the senior vice president directly owned 37,206 shares of the company’s stock, valued at $2,812,029.48. This represents a 4.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 407,226 shares of company stock worth $32,375,888 over the last quarter. Insiders own 39.50% of the company’s stock.

IPG Photonics Trading Down 0.4%

NASDAQ IPGP opened at $74.22 on Friday. IPG Photonics Corporation has a 1-year low of $48.59 and a 1-year high of $92.21. The firm’s fifty day simple moving average is $81.38 and its 200-day simple moving average is $78.61. The company has a market capitalization of $3.13 billion, a PE ratio of 121.66, a price-to-earnings-growth ratio of 19.33 and a beta of 1.02.

IPG Photonics (NASDAQ:IPGP) last released its quarterly earnings data on Tuesday, November 4th. The semiconductor company reported $0.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.19. IPG Photonics had a return on equity of 2.35% and a net margin of 2.66%.The firm had revenue of $250.79 million during the quarter, compared to analysts’ expectations of $240.18 million. IPG Photonics has set its Q4 2025 guidance at 0.050-0.350 EPS. As a group, analysts predict that IPG Photonics Corporation will post 1.54 EPS for the current year.

Analysts Set New Price Targets

IPGP has been the subject of a number of recent analyst reports. Roth Capital set a $96.00 price objective on shares of IPG Photonics and gave the stock a “buy” rating in a research note on Monday, October 6th. Citigroup upgraded IPG Photonics from a “sell” rating to a “buy” rating and increased their target price for the company from $68.00 to $105.00 in a report on Wednesday, November 5th. Weiss Ratings reiterated a “sell (d+)” rating on shares of IPG Photonics in a report on Monday. Benchmark reissued a “hold” rating on shares of IPG Photonics in a research report on Wednesday, December 10th. Finally, Stifel Nicolaus set a $92.00 price objective on IPG Photonics in a research note on Tuesday, November 4th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $89.33.

IPG Photonics Profile

IPG Photonics Corporation is a global leader in the design and manufacture of high-performance fiber lasers and amplifiers used in industrial, medical, scientific, and telecommunications applications. The company’s core products include ytterbium and erbium fiber lasers, diode lasers, and fiber amplifiers that deliver high power and efficiency for precision cutting, welding, marking, and engraving. IPG’s systems are engineered to optimize process speed, reliability, and energy consumption, making them a preferred choice for advanced manufacturing environments.

In addition to stand-alone laser sources, IPG offers turnkey laser systems and integrated solutions tailored to sectors such as automotive, electronics, aerospace, additive manufacturing, and life sciences.